2,6-Dichlorobenzylidene amino guanidine acetate (Wy-8678). A new hypotensive agent.
D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects*; D004195:Disease Models, Animal; D005260:Female; D006145:Guanethidine / Q000494:pharmacology; D006146:Guanidines / Q000494:pharmacology* / Q000627:therapeutic use; D006339:Heart Rate / Q000187:drug effects; D006830:Hydralazine / Q000494:pharmacology; D006973:Hypertension / Q000188:drug therapy*; D008750:Methyldopa / Q000494:pharmacology; D051381:Rats; D012110:Reserpine / Q000494:pharmacology
D000959:Antihypertensive Agents; D006146:Guanidines; D006830:Hydralazine; D008750:Methyldopa; D012110:Reserpine; D006145:Guanethidine